Production (Stage)
Moleculin Biotech, Inc.
MBRX
$0.67
-$0.0201-2.91%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.44M | -1.88M | -10.59M | -4.32M | -4.97M |
| Total Depreciation and Amortization | 31.00K | 31.00K | 32.00K | 31.00K | 32.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.14M | -4.28M | 3.92M | -1.24M | -854.00K |
| Change in Net Operating Assets | 706.00K | 1.05M | 528.00K | -418.00K | -925.00K |
| Cash from Operations | -4.56M | -5.08M | -6.11M | -5.95M | -6.72M |
| Capital Expenditure | -- | 0.00 | 0.00 | -13.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -13.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.00M | 1.00K | 4.66M | -- | -- |
| Repurchase of Common Stock | -- | 0.00 | -1.00K | -25.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.00M | 1.00K | 4.66M | -25.00K | -- |
| Foreign Exchange rate Adjustments | 3.00K | -45.00K | 14.00K | 8.00K | -9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.44M | -5.13M | -1.44M | -5.98M | -6.73M |